Literature DB >> 7318185

Hyperlipidaemia in untreated nephrotic syndrome, increased production or decreased removal?

M K Chan, J W Persaud, L Ramdial, Z Varghese, P Sweny, J F Moorhead.   

Abstract

The relative importance of increased lipoprotein synthesis and decreased lipoprotein catabolism is examined in 13 patients with untreated nephrotic syndrome by the use of intravenous fat tolerance tests analysed in relation to other parameters of lipid metabolism. Increased lipoprotein synthesis in nephrotic patients was indicated by the fact that at a given fractional clearance rate of Intralipid (K2), nephrotic patients had higher serum TG concentrations than did control subjects. A defect in lipoprotein catabolism was also suggested by the frequent finding of intermediate density lipoproteins on electrophoresis and the marginally low (p = 0.05) mean K2 in nephrotic patients. A highly significant (p less than 0.001) positive correlation between HDL-cholesterol concentrations and postheparin fractional clearance rates (K'2) of Intralipid led to the speculation that in the severe nephrotic state (albumin less than 20 g/l) the loss of high density lipoproteins may contribute to the hyperlipidaemia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7318185     DOI: 10.1016/0009-8981(81)90119-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  10 in total

1.  Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat.

Authors:  R W Davies; I Staprans; F N Hutchison; G A Kaysen
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

2.  Serum and urine leptin concentration in children with nephrotic syndrome.

Authors:  Anna Wasilewska; Barbara Tomaszewska; Walentyna Zoch-Zwierz; Anna Biernacka; Krystyna Klewinowska; Alicja Koput
Journal:  Pediatr Nephrol       Date:  2005-03-22       Impact factor: 3.714

Review 3.  Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease.

Authors:  Mona Khurana; Douglas M Silverstein
Journal:  Pediatr Nephrol       Date:  2015-03-24       Impact factor: 3.714

4.  Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion.

Authors:  T Jensen; S Stender; T Deckert
Journal:  Diabetologia       Date:  1988-03       Impact factor: 10.122

5.  Microalbuminuria predicts the development of serum lipoprotein abnormalities favouring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients.

Authors:  L Niskanen; M Uusitupa; H Sarlund; O Siitonen; E Voutilainen; I Penttilä; K Pyörälä
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

Review 6.  [Pathophysiology and therapy of lipid metabolism disorders in kidney diseases].

Authors:  C J Olbricht
Journal:  Klin Wochenschr       Date:  1991-08-01

Review 7.  Lipid changes in the nephrotic syndrome: new insights into pathomechanisms and treatment.

Authors:  G D'Amico
Journal:  Klin Wochenschr       Date:  1991-09-03

Review 8.  Hyperlipidemia in childhood nephrotic syndrome.

Authors:  M A Thabet; J R Salcedo; J C Chan
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

9.  Increased plasma acylation-stimulating protein in pediatric proteinuric renal disease.

Authors:  Jin Hui Tang; Yu Wen; Fei Wu; Xiao Y Zhao; Mei X Zhang; Jie Mi; Katherine Cianflone
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

Review 10.  The Supportive Treatment of IgA Nephropathy and Idiopathic Nephrotic Syndrome: How Useful are Omega-3 Polyunsaturated Fatty Acids?

Authors:  Samuel N Uwaezuoke; Uzoamaka V Muoneke; Ngozi R Mbanefo
Journal:  Int J Nephrol Renovasc Dis       Date:  2020-02-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.